Current Perspectives in ABO-Incompatible Kidney Transplant

References

• Alexander JW, Zola JC. Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant. 1996;10(1 Pt 1):1–19.
   PubMed Web of Science ®Google Scholar
• Ojo AO, Hanson JA, Meier-kriesche H-U, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12(3):589–597. doi:10.1681/ASN.V123589
   PubMed Web of Science ®Google Scholar
• Ministry of Health. Transplants. Italian and European data. Available from: http://www.trapianti.salute.gov.it/trapianti/archivioDatiCnt.jsp. Accessed May 11, 2022.
   Google Scholar
• Henderson ML, Thomas AG, Shaffer A, et al. The national landscape of living kidney donor follow-up in the United States. Am J Transplant. 2017;17(12):3131–3140. doi:10.1111/ajt.14356
   PubMed Web of Science ®Google Scholar
• Stewart DE, Klassen DK. Kidney transplants from HLA-incompatible live donors and survival. N Engl J Med. 2016;375(3):287–288. doi:10.1056/NEJMc1604523
   PubMed Web of Science ®Google Scholar
• Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery. 1964;55:195–200.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Graver B, Terasaki PI. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc. 1987;19(6):4549–4552.
   PubMed Web of Science ®Google Scholar
• Alexandre GP, Squifflet JP, De Bruyère M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987;19(6):4538–4542.
   PubMed Web of Science ®Google Scholar
• Lee HR, Kim K, Lee SW, et al. Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: a network meta-analysis. Medicine. 2021;100(10):e24853. doi:10.1097/MD.0000000000024853
   PubMed Web of Science ®Google Scholar
• Barnett AN, Manook M, Nagendran M, et al. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation. Transpl Int. 2014;27(2):187–196. doi:10.1111/tri.12234
   PubMed Web of Science ®Google Scholar
• Oriol R. ABH and related tissue antigens. Biochem Soc Trans. 1987;15(4):596–599. doi:10.1042/bst0150596
   PubMed Web of Science ®Google Scholar
• Mollicone R, Cailleau A, Oriol R. Molecular genetics of H, Se, Lewis and other fucosyltransferase genes. Transfus Clin Biol. 1995;2(4):235–242. doi:10.1016/S1246-7820(05)80089-8
   PubMed Web of Science ®Google Scholar
• Yamamoto F, Clausen H, White T, et al. Molecular genetic basis of the histo-blood group ABO system. Nature. 1990;345(6272):229–233. doi:10.1038/345229a0
   PubMed Web of Science ®Google Scholar
• Oriol R, Cartron JP, Cartron J, et al. Biosynthesis of ABH and Lewis antigens in normal and transplanted kidneys. Transplantation. 1980;29(3):184–188. doi:10.1097/00007890-198003000-00003
   PubMed Web of Science ®Google Scholar
• Rydberg L, Breimer ME, Brynger H, et al. ABO-incompatible kidney transplantation (A2 to O). Qualitative and semiquantitative studies of the humoral immune response against different blood group A antigens. Transplantation. 1990;49(5):954–960. doi:10.1097/00007890-199005000-00023
   PubMed Web of Science ®Google Scholar
• Rydberg L, Breimer ME, Samuelsson BE, et al. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic, and biochemical approach. Transplant Proc. 1987;19(6):4528–4537.
   PubMed Web of Science ®Google Scholar
• Bohmig GA, Farkas AM, Eskandary F, et al. Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol. 2015;11(12):732–747. doi:10.1038/nrneph.2015.144
   PubMed Web of Science ®Google Scholar
• Rieben R, Buchs JP, Fluckiger E, et al. Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories. Transfusion. 1991;31(7):607–615. doi:10.1046/j.1537-2995.1991.31791368336.x
   PubMed Web of Science ®Google Scholar
• Andersson M, Carlin N, Leontein K, et al. Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. Carbohydr Res. 1989;185(2):211–223. doi:10.1016/0008-6215(89)80036-9
   PubMed Web of Science ®Google Scholar
• Spalter SH, Kaveri SV, Bonnin E, et al. Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. Blood. 1999;93(12):4418–4424. doi:10.1182/blood.V93.12.4418
   PubMed Web of Science ®Google Scholar
• Schlosser HA, Thelen M, Dieplinger G, et al. Prospective analyses of circulating B cell subsets in ABO-compatible and ABO-incompatible kidney transplant recipients. Am J Transplant. 2017;17(2):542–550. doi:10.1111/ajt.14013
   PubMed Web of Science ®Google Scholar
• Mond JJ, Vos Q, Lees A, Snapper CM. T cell independent antigens. Curr Opin Immunol. 1995;7(3):349–354. doi:10.1016/0952-7915(95)80109-X
   PubMed Web of Science ®Google Scholar
• Herzenberg LA. B-1 cells: the lineage question revisited. Immunol Rev. 2000;175:9–22. doi:10.1111/j.1600-065X.2000.imr017520.x
   PubMed Web of Science ®Google Scholar
• Ishida H, Tanabe K, Ishizuka T, et al. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation. Transplantation. 2006;81(5):665–671. doi:10.1097/01.tp.0000185193.77929.96
   PubMed Web of Science ®Google Scholar
• Snapper CM, McIntyre TM, Mandler R, et al. Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992;175(5):1367–1371. doi:10.1084/jem.175.5.1367
   PubMed Web of Science ®Google Scholar
• Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655–692. doi:10.1146/annurev.iy.13.040195.003255
   PubMed Web of Science ®Google Scholar
• Tonti E, Fedeli M, Napolitano A, et al. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4 + T cell help. J Immunol. 2012;188(7):3217–3222. doi:10.4049/jimmunol.1103501
   PubMed Web of Science ®Google Scholar
• Nemes B, Barta A, Ivádi G, et al. T cell subset profile and appearance of donor-specific antibodies in primary and retransplanted kidney recipients. Transplant Proc. 2019;51(4):1215–1225. doi:10.1016/j.transproceed.2019.04.002
   PubMed Web of Science ®Google Scholar
• Park WD, Grande JP, Ninova D, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant. 2003;3(8):952–960. doi:10.1034/j.1600-6143.2003.00179.x
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Miwa Y, Ogawa H, et al. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation. Transplantation. 2012;93(4):390–397. doi:10.1097/TP.0b013e3182424df3
   PubMed Web of Science ®Google Scholar
• Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev. 2013;27(1):1–8. doi:10.1016/j.trre.2012.07.003
   Web of Science ®Google Scholar
• Chen Song S, Zhong S, Xiang Y, et al. Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates. Am J Transplant. 2011;11(10):2057–2066. doi:10.1111/j.1600-6143.2011.03646.x
   PubMed Web of Science ®Google Scholar
• Koestner SC, Kappeler A, Schaffner T, et al. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation. Lancet. 2004;363(9420):1523–1525. doi:10.1016/S0140-6736(04)16179-5
   PubMed Web of Science ®Google Scholar
• Tanabe T, Ishida H, Horita S, et al. Endothelial chimerism after ABO-incompatible kidney transplantation. Transplantation. 2012;93(7):709–716. doi:10.1097/TP.0b013e31824612b5
   PubMed Web of Science ®Google Scholar
• Barbolla L, Mojena M, Cienfuegos JA, et al. Presence of an inhibitor of glycosyltransferase activity in a patient following an ABO incompatible liver transplant. Br J Haematol. 1988;69(1):93–96. doi:10.1111/j.1365-2141.1988.tb07608.x
   PubMed Web of Science ®Google Scholar
• West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001;344(11):793–800. doi:10.1056/NEJM200103153441102
   PubMed Web of Science ®Google Scholar
• Urschel S, Campbell PM, Meyer SR, et al. Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant. 2010;10(1):149–156. doi:10.1111/j.1600-6143.2009.02877.x
   PubMed Web of Science ®Google Scholar
• Genberg H, Kumlien G, Wennberg L, et al. Isoagglutinin adsorption in ABO-incompatible transplantation. Transfus Apher Sci. 2010;43(2):231–235. doi:10.1016/j.transci.2010.07.016
   PubMed Web of Science ®Google Scholar
• Cen M, Wang R, Kong W, et al. ABO-incompatible living kidney transplantation. Clin Transplant. 2020;34(9):e14050. doi:10.1111/ctr.14050
   PubMed Web of Science ®Google Scholar
• Tanabe K. Double-filtration plasmapheresis. Transplantation. 2007;84(12 Suppl):S30–2. doi:10.1097/01.tp.0000296103.34735.b8
   PubMed Web of Science ®Google Scholar
• Biglarnia AR, Nilsson B, Nilsson Ekdahl K, et al. Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation. Transplantation. 2012;93(1):87–92. doi:10.1097/TP.0b013e31823bb689
   PubMed Web of Science ®Google Scholar
• Schiesser M, Steinemann DC, Hadaya K, et al. The reuse of immunoadsorption columns in ABO-incompatible kidney transplantation is efficient: the Swiss experience. Transplantation. 2015;99(5):1030–1035. doi:10.1097/TP.0000000000000457
   PubMed Web of Science ®Google Scholar
• Tobian AA, Shirey RS, Montgomery RA, et al. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion. 2008;48(11):2453–2460. doi:10.1111/j.1537-2995.2008.01857.x
   PubMed Web of Science ®Google Scholar
• Tobian AA, Shirey RS, Montgomery RA, et al. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion. 2009;49(6):1248–1254. doi:10.1111/j.1537-2995.2008.02085.x
   PubMed Web of Science ®Google Scholar
• Tyden G, Donauer J, Wadström J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation–a three-center experience with 60 consecutive transplantations. Transplantation. 2007;83(9):1153–1155. doi:10.1097/01.tp.0000262570.18117.55
   PubMed Web of Science ®Google Scholar
• Montgomery RA, Locke JE, King KE, et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation. 2009;87(8):1246–1255. doi:10.1097/TP.0b013e31819f2024
   PubMed Web of Science ®Google Scholar
• Speer C, Kälble F, Nusshag C, et al. Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study. Transpl Int. 2019;32(12):1286–1296. doi:10.1111/tri.13482
   PubMed Web of Science ®Google Scholar
• Becker LE, Siebert D, Süsal C, et al. Outcomes following ABO-incompatible kidney transplantation performed after desensitization by nonantigen-specific immunoadsorption. Transplantation. 2015;99(11):2364–2371. doi:10.1097/TP.0000000000000753
   PubMed Web of Science ®Google Scholar
• Genberg H, Kumlien G, Wennberg L, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation. 2008;85(12):1745–1754. doi:10.1097/TP.0b013e3181726849
   PubMed Web of Science ®Google Scholar
• Okumi M, Toki D, Nozaki T, et al. ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management. Am J Transplant. 2016;16(3):886–896. doi:10.1111/ajt.13502
   PubMed Web of Science ®Google Scholar
• Kohei N, Hirai T, Omoto K, et al. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period. Am J Transplant. 2012;12(2):469–476. doi:10.1111/j.1600-6143.2011.03830.x
   PubMed Web of Science ®Google Scholar
• Subramanian V, Gunasekaran M, Gaut JP, et al. ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens. Hum Immunol. 2016;77(1):76–83. doi:10.1016/j.humimm.2015.10.014
   PubMed Web of Science ®Google Scholar
• Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant. 2004;4(8):1315–1322. doi:10.1111/j.1600-6143.2004.00507.x
   PubMed Web of Science ®Google Scholar
• Gloor J, Stegall M. ABO-incompatible kidney transplantation with and without splenectomy. Transplantation. 2006;82(5):720. doi:10.1097/01.tp.0000229428.03414.b2
   PubMed Web of Science ®Google Scholar
• Kamburova EG, Koenen HJ, Borgman KJE, et al. A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function. Am J Transplant. 2013;13(6):1503–1511. doi:10.1111/ajt.12220
   PubMed Web of Science ®Google Scholar
• Uchida J, Machida Y, Iwai T, et al. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study. Clin Transplant. 2014;28(1):80–87. doi:10.1111/ctr.12281
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Liu D, Ogawa H, et al. Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (ABase) for ABO-incompatible transplantation. Transpl Immunol. 2009;20(3):132–138. doi:10.1016/j.trim.2008.09.007
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Kato Y, Kaneko MK, et al. Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation. Transplantation. 2008;85(3):378–385. doi:10.1097/TP.0b013e3181612f84
   PubMed Web of Science ®Google Scholar
• Ye Y, Niekrasz M, Kehoe M, et al. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: the baboon as a model for the human. Lab Anim Sci. 1994;44(2):121–124.
   PubMedGoogle Scholar
• Wongsaroj P, Kahwaji J, Vo A, Jordan SC. Modern approaches to incompatible kidney transplantation. World J Nephrol. 2015;4(3):354–362. doi:10.5527/wjn.v4.i3.354
   PubMedGoogle Scholar